Astrocyte Senescence as a Component of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n = 4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n = 6; P = 0.02) and 78 to 90 years (n = 11; P<10(-6)). In addition, the frontal cortex of AD patients (n = 15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n = 25; P = 0.02) and fetal controls (n = 4; P<10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (Aβ(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In many prevalent neurodegenerative conditions including Alzheimer's Disease, brain tissue biopsies are present with increased levels of p16INK4a- positive astrocytes, MMP-1 and IL-6”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Astrocytes cultured from patients with AD express not only more of the CDKi p16 INK4A than age-matched controls, but also more MMP1 and IL-6 (57).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have highlighted senescence in multiple brain cell types in AD [3, 16, 32, 52, 80].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the context of aging and neurodegenerative disease, senescent cell accumulation has been identified in multiple cell types within the central nervous system (CNS), including neurons6,7,14,15, astrocytes16,17, microglia8,18, oligodendrocyte precursor cells19 and endothelial cells20.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, prior research conducted on postmortem brain tissue from individuals with AD has identified senescent astrocytes16, and mouse models have demonstrated that they are cleared with senolytic treatment8,17.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Staining for Senescence-associated b-galactosidase Senescence-associated beta-galactosidase (SA b-gal) staining was performed as previously described [62].”
MethodThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 11×
“One component of the SASP present in multiple cell types is IL-6.”
BackgroundInfluentialAstrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 1×
“Astrocytes regulate the contents of the synaptic cleft and synaptic transmission as part of the tripartite synapse, control CNS metabolism, and maintain blood brain barrier integrity [10,11].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The increased dosage of synthetic versus cell-derived Ab oligomers required to trigger senescence, correlates with reports on the effects of Ab on rat hippocampal long-term potentiation [53].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“demonstrated by the phenotypic improvement observed following the targeted removal of senescent cells in a progeroid mouse model [9].”
BackgroundInfluentialMechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · cited 1×
“In vitro, we found that exposure of astrocytes to Ab1–42 triggers senescence and that senescent astrocytes produce high quantities of interleukin-6 (IL-6), a cytokine known to be increased in the CNS of AD patients [18].”
Background2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“We selected the age ranges of 35–50 years and 78–90 years (Figure 3B) in order to compare a group that is least likely to have AD and a group that is most likely to have AD [31].”
MethodBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Cited by
Items 501–589 of 589
Contribution of Nucleic Acids in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00004-5 · Cited by 1
Suárez, U. P. D. N. I. N. D. N. Y. N. M. V., Torres-Ramos, M., & Morales-López, B. I. (2022) · eNeurobiología · doi:10.25009/eb.v13i32.2604 · Cited by 2
Lautrup, S., Anisimov, A. S., Lagartos-Donate, M. J., & Fang, E. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91617-2.00010-9 · Cited by 4
Sessions, G. A., Loops, M. V., Diekman, B. O., & Purvis, J. E. (2025) · GeroScience · doi:10.1007/s11357-024-01503-7 · Cited by 3
“Cellular senescence is a phenotypic state associated with diseases that emerge at high rates with aging, such as osteoarthritis [2–4], neurodegenerative disorders [5, 6], and macular degeneration [7].”
James, E. L., Teh, M., Li, Y., Wagner-Bock, C., Al-Khateeb, Z. F., Karen‐Ng, L. P., Roberts, T., Synchyshyn, L., Lewis, A. L., O’Loghlen, A., et al. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1583288 · Cited by 4
“As p38MAPK is activated in numerous types of senescent cells, including astrocytes (Bhat et al., 2012), these results suggested that EC may also accumulate in these senescent cell types.”
Reina-Gonzalez, P., Ay, M., Langley, M. R., Plunk, E. C., Strazdins, R., Abu-Salah, A., Anchan, A., Shah, A., & Sarkar, S. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf088 · Cited by 2
Huang, S., Li, J., Gu, D., Li, Z., Chen, H., & Xiong, W. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1623875 · Cited by 3
“These pathological alterations are strongly associated with cellular senescence, a process that may be modulated by the activity of gut microbes (Bhat et al., 2012).”
Age-Linked Non-Transmissible Diseases
Swynghedauw, B. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-15111-9_6 · Cited by 1
The Glial Aging & Senescence Hypothesis of Late-onset Alzheimer’sPreprint
Lau, V. Z., Ramer, L. M., & Tremblay, M. (2022) · Preprints.org · doi:10.20944/preprints202109.0437.v2 · Cited by 1
Faculty Opinions recommendation of Astrocyte senescence: Evidence and significance.
Rattan, S. I. S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735180286.793557427 · Cited by 1
Santín-Márquez, R. (2023) · doi:10.24275/uami.ht24wj673 · Cited by 1
Khojah, S. M. (2015) · Enlighten: Theses (The University of Glasgow)
An Integrative View on Intra- and Inter-Cellular Cooperation Mechanisms in Alzheimer's Disease
Enciu, A., Parhon, C. I., & Babes, V. (2014)
THE RELEVANCE OF MICRORNAS IN VASCULAR AGING
Wong, P., & Jong, H. L. (2014) · Journal of Health and Translational Medicine · doi:10.22452/jummec.vol17no2.4
Kohli, N. (2012) · STARS (University of Central Florida)
Vázquez-Villaseñor, I. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Targeting Astrocytes With Viral Gene Therapy for Alzheimer’s Disease
Rosenthal, Z. P., Kraft, A. W., Czerniewski, L. R., & Lee, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00005-3 · Cited by 1
Optic Nerve of Zebrafish (Danio rerio): An Animal Model for Human Aging
González, P. (2017)
Waaijer, M. E. C., Tuttle, C. S. L., Westendorp, R. G. J., & Maier, A. B. (2018) · VU Research Portal
Moreira, N. C. D. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-26072019-171040 · Cited by 1
Senotherapeutics: Experimental therapy of cellular senescence
Justice, J. N., Niedernhofer, L. J., & Orr, M. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00012-3
TERT-dependent senescence and inflammation in ageing, using zebrafish as a model
Martins, R. R. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
The APOE4 Mouse as a Model of Chemotherapy-induced Cognitive Impairments and Senescence
Demby, T. C. (2021) · DigitalGeorgetown (Georgetown University Library)
Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicityPreprint
Perez‐Nievas, B. G., Johnson, L., Beltran-Lobo, P., Hughes, M. M., Gammallieri, L., Tarsitano, F., Myszczynska, M. A., Vázquez-Villaseñor, I., Jiménez-Sánchez, M., Troakes, C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.22.458716
How Senescent Glia Drive And Underlie Alzheimer’s Disease: A Predictive ModelPreprint
Lau, V. Z., Ramer, L. M., & Tremblay, M. (2021) · Preprints.org · doi:10.20944/preprints202109.0437.v1
Cellular senescence in the ageing brain: to eliminate or not to eliminate?
Talma, N. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.206630102
Muñoz‐Cánoves, P. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734035096.793551787
Ha, T.-Y., Choi, Y. R., Noh, H. R., Cha, S., Kim, J.-B., & Park, S. M. (2020) · Research Square · doi:10.21203/rs.3.rs-102606/v1
Editorial: Role of Senescence in Neurodegenerative Diseases
Tüzer, F., Chinta, S. J., & Viel, T. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.907670
“One demonstrates that astrocyte cellular senescence, which increases with age (Bhat et al., 2012), is toxic to neuronal health.”
BackgroundSenescence and its Effect on Aging and Dementia
Khaliq, F. (2022) · Journal of Regenerative Biology and Medicine · doi:10.37191/mapsci-2582-385x-4(3)-114 · Cited by 1
Cellular senescence due to physical inactivity: A review
Selvam, S., Ramesh, S., & Ramasubramanian, A. (2019) · International Journal of Histopathological Interpretation · doi:10.4103/ijhi.ijhi_7_22
SCN9A : Proposal of Voltage-Gated Ion Channels as a Novel Diagnostic Marker for Alzheimer’s DiseasePreprint
Shah, D., Shah, R., Waldron, A., & Leonardi, D. (2023) · medRxiv · doi:10.1101/2023.05.18.23289925
Horkulak, N. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10060
The Aging of Cells: Cellular Senescence and Implications for Age-Related Diseases
Kim, A., & Yoo, J. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i3.4847
Xu, P., Wang, M., Song, W., Wang, Q., Yuan, G., Sudmant, P. H., Zare, H., Tu, Z., Orr, M. E., & Zhang, B. (2022) · Figshare · doi:10.6084/m9.figshare.18094452
Huang, L., Tüzer, F., Murtha, A., Green, M. S., Torres, C. A., Liu, H., & Malaeb, S. (2024) · Anesthesiology Research and Practice · doi:10.1155/2024/8876548
“Te cumulative population doubling (PD) level was then calculated as previously described [8, 21] using the formula NH/NI � 2 x , where NH represents the number of cells at harvest, NI represents the initial number of seeded cells or inoculum, and x is the number of population doublings.”
BackgroundMethodSelf-citationJames, E. L., Teh, M., Li, Y., Wagner-Bock, C., Al-Khateeb, Z. F. H., Karen‐Ng, L. P., Roberts, T., Synchyshyn, L., Lewis, A. L., O’Loghlen, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.30.609895
Pharmacological Interventions for Maintaining Brain Health in Ageing
Sathaye, S. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_14 · Cited by 1
Sessions, G. A., Loops, M. V., Diekman, B. O., & Purvis, J. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.14.618296
Human aged astrocytes induce neurotoxicity in response to inflammatory stimuliPreprint
Kobayashi, H., Maeda, K., Wakui, T., Kazetani, K., Nabetani, A., Shin, E., Kato, H., & Endoh‐Yamagami, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.17.670762
“Increased cellular senescence marker p16-positive astrocytes have been reported in the normal aged brain and in the brains of AD patients 14 .”
Senolytic Therapy as a Preventive Strategy for Low Back PainPreprint
Darband, S. G., Cherif, H., Mannarino, M., Sagir, J., Millecamps, M., Ouellet, J. A., Stone, L. S., & Haglund, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.08.681005
Sommer, N., Pacheco, A., Jorge Carvajal, C., Olguín, H. C., Leiva, A., Gutiérrez, J., & Marzolo, M. (2025) · Research Square · doi:10.21203/rs.3.rs-7934067/v1
Neurological aging and neurodegenerative disease in humans and great apes
Edler, M. K., Hearn, C. J., Guevara, E. E., Mhatre‐Winters, I., Varghese, M., Freire‐Cobo, C., Sherwood, C. C., Richardson, J. R., Raghanti, M. A., & Hof, P. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27380-3.00074-9 · Cited by 1
Xu, P., Wang, M., Song, W.-M., Wang, Q., Yuan, G., Sudmant, P. H., Zare, H., Tu, Z., Orr, M. E., & Zhang, B. (2022) · Figshare · doi:10.6084/m9.figshare.18094446
Xia, M.-L., Xie, X.-H., Ding, J.-H., Du, R.-H., & Hu, G. (2020) · Figshare · doi:10.6084/m9.figshare.12097050
Dai, D. L., Li, M., & Lee, E. B. (2024) · Figshare · doi:10.6084/m9.figshare.26608141
Ha, T.-Y., Choi, Y. R., Noh, H. R., Cha, S.-H., Kim, J.-B., & Park, S. M. (2021) · Figshare · doi:10.6084/m9.figshare.15071404
Dai, D. L., Li, M., & Lee, E. B. (2024) · Figshare · doi:10.6084/m9.figshare.26608144
Bientinesi, E., Vignoli, A., Ristori, S., Salobehaj, M., Bertoni, G., Monti, D., & Tenori, L. (2026) · Metabolites · doi:10.3390/metabo16030173
“Amyloid β -Protein (1-42) (#4014447; Bachem, Bubendorf, Switzerland) was prepared and oligomerized as previously described [19].”
Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases
Liu, R.-M., & Nakamya, M. F. (2026) · Cells · doi:10.3390/cells15060551 · Cited by 1
“Senescent cells, including astrocytes, microglia, neurons, and endothelial cells, have been detected in the brain of AD patients [42,226,227,229–234] and in AD model mice [42,228–230 , 235].”
Reelin regulates the migration and differentiation of extravillous trophoblastic cells
Sommer, N., Alarcón-Godoy, C., Pizarro, H., Pacheco, A., Jorge Carvajal, C., Olguín, H. C., Gutiérrez, J., Leiva, A., & Marzolo, M. (2026) · Biological Research · doi:10.1186/s40659-026-00690-1 · Cited by 1
“Likely, increased senescence has been linked with age-related neurodegenerative diseases such as Alzheimer’s and Parkinson’s [120, 121], while Reelin treatment alleviates it [122, 123].”
de Freitas, J. A. N. L. F. (2020) · theses.fr (ABES) · doi:10.70675/0e6e3614z3915z4fb8za2cdz24b40b9679b2
Study of the Neuron-Astrocyte Relationship in a Rodent Model of Tauopathy
de Gérando, A. M. (2019) · theses.fr (ABES) · doi:10.70675/04658671zaca3z4fefza24dz2f5a011bebfe
Hétérogénéité de la réactivité astrocytaire dans la maladie d'Alzheimer
Guillemaud, O. (2020) · theses.fr (ABES) · doi:10.70675/038d98c5z55ccz4754z9af9z417e3826d282
Dissecting the impact of cellular senescence on muscle regeneration
Cazin, C. (2020) · theses.fr (ABES) · doi:10.70675/42a7ff38zb338z4eb8za925z2ce0a01ee74e
Characterization and impact of cellular senescence during mammary gland involution
Charifou, E. (2022) · theses.fr (ABES) · doi:10.70675/54491057z33e4z449fzb26fz6a2e42b1a22e
Control of ependymal cell differentiation by the mTOR signaling pathway
Srivastava, A. (2021) · theses.fr (ABES) · doi:10.70675/0e4dc286zfb40z4d2bza4cdzd6fdff1cc2e8
Lazzarotto, A. (2023) · theses.fr (ABES) · doi:10.70675/245e2c82zb2bdz4b9dzbd16zc18dbdc9732b
Mazeyrie, L. (2024) · theses.fr (ABES) · doi:10.70675/04dabd62z8f26z4393zac25z0070faaa4fb9
Astrocytes dysfunction in tauopathies
Augustin, E. (2023) · theses.fr (ABES) · doi:10.70675/a6b6a2f4zff42z4987z9ca0z62aca30c291c
Characterization of Cellular Senescence in Primary Human AstrocytesPreprint
Woodham, T. A., Kelsey, M. M. G., & Sedivy, J. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.29.721581 · Cited by 3
Demir, E. I., & Sezer, G. (2026) · Cell and Tissue Biology · doi:10.1134/s1990519x26600195 · Cited by 1
Prokopov, A., Дробинцева, А. О., Любякина, П. Н., & Kvetnoy, I. M. (2026) · Успехи геронтологии · doi:10.34922/ae.2026.39s
Redox bioenergetics of neuronal senescence in Alzheimer’s disease
Atasever, E., Turgut, Ş., Andican, G., & Çakatay, U. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.002 · Cited by 1
Senolytic Therapy as a Preventive Strategy for Spine Degeneration and Pain
Darband, S. G., Cherif, H., Mannarino, M., Sagir, J., Millecamps, M., Ouellet, J. A., Stone, L. S., & Haglund, L. (2026) · Advanced Science · doi:10.1002/advs.202522770 · Cited by 2
Zhou, R., Yang, J., Chen, L., 彭, 思., Feng, X., Zhang, X., & Song, J. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102255
CCN1/Cyr61 associates with β-amyloid levels in human cerebrospinal fluids
Shinohara, M., Momota, H., Saito, T., Takenobu, C., Kasuga, K., Gheni, G., Kawai, K., Morishima, M., Saito, Y., Shindo, A., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116244
“3,4 Previously, astrocytic senescence was reported in human AD, 5 and recently, senescent microglial cells have been discovered in AD model mice, 6 and it has been suggested that removing senescent cells using senolytic reagents may suppress the progression of neurodegenerative diseases including…”
InfluentialSenescent cell heterogeneity in brain aging and neurodegenerative disease
Graves, S. I., Vasques, P. D. C., & Baker, D. J. (2026) · Neuron · doi:10.1016/j.neuron.2026.06.020
Brain aging clocks: From methodological advances to cellular mechanisms
Suk, K. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113260
Cellular senescence and senolytic therapy in traumatic brain injury
Brann, D. W., Singh, H. D., Wang, J., Lu, Y., Carr, C., & Dhandapani, K. M. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1862748
Hai, H., Li, M., Hu, X., Peng, J., & He, Z. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1875385 · Cited by 1
“Senescent astrocytes release a variety of pro-inflammatory factors, including IL-6, IL-1 β , and TNF-α , which contribute to neuroin-flammation and neuronal damage (21–24).”
Homeostatic conflict as a driver for brain aging
Wulkop-Gil, C. A., & Petrascheck, M. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1881856
“…and altered territorial organization (Grosche et al., 2013; Popov et al., 2021), and select populations of both cell types acquire aberrant, pro-inflammatory, and senescent states (Sala Frigerio et al., 2019; Liddelow et al., 2017; Bhat et al., 2012; Cohen and Torres, 2019; Iram et al., 2016).”
Genotoxic and metabolic stress drive divergent senescence programs in human microgliaPreprint
Jose, N. V., Janssens, S., Kang, E., & Platt, B. (2026) · Research Square · doi:10.21203/rs.3.rs-10751142/v1
Momand, M. U. D., Macová, K., & Fričová, D. (2026) · Aging Cell · doi:10.1111/acel.70719
“In AD, p16 INK4a - and MMP-1 positive senescent astrocytes accumulate in the cortex and hippocampus (Bhat et al. 2012).”
InfluentialMakhlouf, H., Dorigatti, A. O., Hernandez, S. F., de Rosa, N., Miller, L. R., Hussong, S. A., Holstein, D. M., Lechleiter, J. D., Logan, S., Kayed, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.08.750215
Metabolomic Biomarkers of Cellular Senescence in Neurodegenerative Disease
Slocum, D. L., Duka, D., Antonelli, L., & Logan, R. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1018049
Astrocyte Structure–Function Relationship in Senescence and Neurodegeneration
Serebryanaya, D. V., Kolgaeva, K. A., Dya, G. A., Ermakov, I. M., & Belousov, V. V. (2026) · Biochemistry (Moscow) · doi:10.1134/s000629792660208x
“Senes-cent astrocytes also develop a characteristic SASP, including increased production of matrix metalloproteinases such as MMP-1, whose levels correlate with p16INK4a expression [41].”
InfluentialCellular senescence in multiple sclerosis: hallmarks, immunosenescence, and therapeutic implications
Yousef, A., Seubert, J. M., Power, C., & Nathoo, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1944657
Verma, A., Goyal, A., Agrawal, N., & Yadav, H. N. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111985
Bindal, P., Kasher, P. R., & Ogawa, S. (2026) · GeroScience · doi:10.1007/s11357-026-02619-8
Metadata
- Authors
- Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C.
- Affiliations
- Drexel University (US)
- University of Pennsylvania (US)
- Corresponding author
- Torres, Claudio
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-12
- Volume
- 7
- Issue
- 9
- Pages
- e45069
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3440417
- OpenAlex
- W2026433865
- Cited by
- 586
- References
- 64
- Citations by year
- 2026: 44 · 2025: 56 · 2024: 68 · 2023: 54 · 2022: 52 · 2021: 59 · 2020: 53 · 2019: 47 · 2018: 37 · 2017: 27 · 2016: 31 · 2015: 17 · 2014: 30 · 2013: 7 · 2012: 3
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Drexel University
- National Institutes of Health
- University of California, San Diego
- College of Medicine, Drexel University
- National Institute on Aging (AG022443-S1, AG022443, R01AG022443)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- astrocyte senescence, Alzheimer's disease, aging, p16INK4a, MMP-1, amyloid-beta 42, oxidative stress, senescence-associated β-galactosidase, interleukin-6, p38 MAPK, neuroinflammation, frontal cortex, sporadic Alzheimer's disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Astrocytes, Brain, Cells, Cultured, Cricetulus, Female, Cricetinae, Humans, Male, Microscopy, Fluorescence, Middle Aged, Peptide Fragments, Immunoblotting, Biomarkers, Interleukin-6, Amyloid beta-Peptides, CHO Cells, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Matrix Metalloproteinase 1, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.